[BONRAYBIO] Announcement of Important Resolutions from the 2026 Annual General Meeting of Shareholders
Key facts
- [BONRAYBIO] Announcement of Important Resolutions from the 2026 Annual General Meeting of Shareholders
- BONRAYBIO held its annual general meeting on May 20, 2026, approving the 2025 financial reports and dividend distributions. It also resolved to increase capital through retained earnings and capital reserves, amended asset disposal procedures, and lifted non-compete clauses for directors.
- Source: PR Times
- Date: May 20, 2026
Direct answer
BONRAYBIO held its annual general meeting on May 20, 2026, approving the 2025 financial reports and dividend distributions. It also resolved to increase capital through retained earnings and capital reserves, amended asset disposal procedures, and lifted non-compete clauses for directors.
- Citation
- [BONRAYBIO] Announcement of Important Resolutions from the 2026 Annual General Meeting of Shareholders (May 20, 2026), PR Times
- Source
- PR Times
- Date
- May 20, 2026
BONRAYBIO held its annual general meeting on May 20, 2026, approving the 2025 financial reports and dividend distributions. It also resolved to increase capital through retained earnings and capital reserves, amended asset disposal procedures, and lifted non-compete clauses for directors.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 09:00
- 🔍 Collected: May 21, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 21, 2026 at 08:06 (6 min after Collected)
1. Date of the Annual General Meeting: May 20, 2026
2. Important Resolution I: Earnings Distribution or Deficit Compensation: Approval of the company's 2025 earnings distribution plan.
3. Important Resolution II: Amendment of Articles of Incorporation: None.
4. Important Resolution III: Business Report and Financial Statements: Approval of the company's 2025 business report and financial statement proposal.
5. Important Resolution IV: Election of Directors and Supervisors: None.
6. Important Resolution V: Other Matters:
(1) Approval of the capital increase through the issuance of new shares funded by earnings and capital reserves.
(2) Approval of the amendment to the company's 'Procedures for Acquisition or Disposal of Assets'.
(3) Approval of the lifting of non-compete restrictions on directors and their representatives.
7. Other matters to be specified: None.
2. Important Resolution I: Earnings Distribution or Deficit Compensation: Approval of the company's 2025 earnings distribution plan.
3. Important Resolution II: Amendment of Articles of Incorporation: None.
4. Important Resolution III: Business Report and Financial Statements: Approval of the company's 2025 business report and financial statement proposal.
5. Important Resolution IV: Election of Directors and Supervisors: None.
6. Important Resolution V: Other Matters:
(1) Approval of the capital increase through the issuance of new shares funded by earnings and capital reserves.
(2) Approval of the amendment to the company's 'Procedures for Acquisition or Disposal of Assets'.
(3) Approval of the lifting of non-compete restrictions on directors and their representatives.
7. Other matters to be specified: None.
FAQ
What was decided at BONRAYBIO's shareholder meeting?
Approval of the 2025 financial reports, dividend distribution, new share issuance, and amendments to asset procedures were resolved.
What impact does this have on investors?
It signals a capital increase and strengthens the company's financial stability.
When can business developments be expected?
Business investments linked to the capital increase are expected in the coming months.